In Germany, LEON‑nanodrugs and Harro Höfliger Verpackungsmaschinen GmbH have signed a strategic collaboration to expand the global distribution and after-sales support for LEON’s nanoencapsulation equipment, a platform increasingly central to advanced therapy manufacturing.
Under the terms of the agreement, Harro Höfliger will serve as a non-exclusive authorised partner to commercialise and service LEON’s FR-JET-based systems worldwide, providing pharmaceutical and biotech customers with broader access to scalable lipid nanoparticle (LNP) production technology.
This is seen as a critical enabler for modern biologics and RNA-based medicines.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.
